| Primary |
| Depression |
37.8% |
| Product Used For Unknown Indication |
29.7% |
| Drug Use For Unknown Indication |
7.8% |
| Anxiety |
3.5% |
| Insomnia |
2.9% |
| Major Depression |
2.5% |
| Schizoaffective Disorder |
2.5% |
| Schizophrenia |
2.1% |
| Depressed Mood |
1.8% |
| Hypertension |
1.7% |
| Psychotic Disorder |
1.5% |
| Sleep Disorder |
1.5% |
| Pain |
1.0% |
| Depressive Symptom |
0.6% |
| Suicide Attempt |
0.6% |
| Agitation |
0.6% |
| Bipolar Disorder |
0.5% |
| Drug Exposure During Pregnancy |
0.5% |
| Overdose |
0.5% |
| Hepatitis C |
0.4% |
|
| Completed Suicide |
7.7% |
| Serotonin Syndrome |
7.6% |
| Hyponatraemia |
6.9% |
| Suicidal Ideation |
6.6% |
| Vomiting |
6.5% |
| Somnolence |
6.3% |
| Weight Increased |
6.2% |
| Tremor |
6.0% |
| Overdose |
5.2% |
| Restless Legs Syndrome |
4.9% |
| Rhabdomyolysis |
4.7% |
| Suicide Attempt |
4.5% |
| Weight Decreased |
4.0% |
| Syncope |
3.7% |
| Inappropriate Antidiuretic Hormone Secretion |
3.6% |
| Tachycardia |
3.6% |
| Neuroleptic Malignant Syndrome |
3.2% |
| Oedema Peripheral |
3.0% |
| Toxicity To Various Agents |
3.0% |
| Drug Interaction |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
33.0% |
| Depression |
20.1% |
| Drug Use For Unknown Indication |
15.9% |
| Anxiety |
5.1% |
| Psychotic Disorder |
2.7% |
| Drug Abuse |
2.6% |
| Hypertension |
2.2% |
| Insomnia |
2.2% |
| Schizophrenia |
2.2% |
| Major Depression |
2.1% |
| Schizoaffective Disorder |
2.0% |
| Suicide Attempt |
1.8% |
| Bipolar Disorder |
1.6% |
| Pain |
1.5% |
| Depressed Mood |
1.1% |
| Parkinson's Disease |
0.9% |
| Sleep Disorder |
0.9% |
| Foetal Exposure During Pregnancy |
0.9% |
| Ill-defined Disorder |
0.6% |
| Post-traumatic Stress Disorder |
0.6% |
|
| Completed Suicide |
13.6% |
| Suicide Attempt |
9.3% |
| Toxicity To Various Agents |
9.2% |
| Respiratory Arrest |
7.9% |
| Death |
5.3% |
| Overdose |
5.3% |
| Serotonin Syndrome |
5.0% |
| Pancreatitis Acute |
4.7% |
| Vomiting |
4.4% |
| Poisoning |
4.0% |
| Tachycardia |
3.9% |
| Weight Increased |
3.7% |
| Tremor |
3.7% |
| Somnolence |
3.3% |
| Suicidal Ideation |
3.1% |
| Drug Abuse |
3.0% |
| White Blood Cell Count Decreased |
2.8% |
| Drug Toxicity |
2.7% |
| Pulmonary Embolism |
2.6% |
| Cardio-respiratory Arrest |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.8% |
| Depression |
16.6% |
| Drug Use For Unknown Indication |
11.9% |
| Pain |
5.7% |
| Hypertension |
5.6% |
| Anxiety |
4.2% |
| Insomnia |
2.9% |
| Schizophrenia |
2.8% |
| Sleep Disorder |
2.2% |
| Bipolar Disorder |
1.9% |
| Hepatitis C |
1.8% |
| Rheumatoid Arthritis |
1.7% |
| Diabetes Mellitus |
1.7% |
| Prophylaxis |
1.6% |
| Osteoporosis |
1.5% |
| Hiv Infection |
1.5% |
| Major Depression |
1.5% |
| Psychotic Disorder |
1.4% |
| Nausea |
1.4% |
| Multiple Myeloma |
1.3% |
|
| Vomiting |
12.8% |
| Weight Decreased |
9.3% |
| Weight Increased |
7.7% |
| Type 2 Diabetes Mellitus |
6.5% |
| Urinary Tract Infection |
5.8% |
| Withdrawal Syndrome |
5.2% |
| Death |
5.0% |
| Suicidal Ideation |
4.8% |
| Tremor |
4.6% |
| Pneumonia |
4.3% |
| Suicide Attempt |
4.0% |
| White Blood Cell Count Increased |
3.8% |
| Myocardial Infarction |
3.8% |
| Nausea |
3.4% |
| Pulmonary Embolism |
3.4% |
| Tachycardia |
3.4% |
| Vision Blurred |
3.2% |
| White Blood Cell Count Decreased |
3.1% |
| Drug Ineffective |
3.1% |
| Renal Failure Acute |
2.9% |
|
| Interacting |
| Hypertension |
18.5% |
| Depression |
18.0% |
| Product Used For Unknown Indication |
11.5% |
| Insomnia |
10.1% |
| Anxiety |
7.3% |
| Drug Use For Unknown Indication |
4.9% |
| Decreased Appetite |
4.6% |
| Type 2 Diabetes Mellitus |
3.4% |
| Pain |
3.2% |
| Ewing's Sarcoma |
2.8% |
| Psychotic Disorder |
2.2% |
| Hiv Infection |
2.1% |
| Asthma |
1.9% |
| Analgesic Therapy |
1.6% |
| Major Depression |
1.6% |
| Sedation |
1.6% |
| Neck Pain |
1.4% |
| Parkinson's Disease |
1.2% |
| Extrapyramidal Disorder |
1.0% |
| Hypothyroidism |
0.8% |
|
| Drug Interaction |
15.6% |
| Blood Sodium Decreased |
12.5% |
| Alcohol Interaction |
7.5% |
| Cognitive Disorder |
7.5% |
| Syncope |
5.6% |
| Urinary Hesitation |
5.0% |
| Rash |
4.4% |
| Rhabdomyolysis |
4.4% |
| Serotonin Syndrome |
4.4% |
| Circulatory Collapse |
3.8% |
| Lethargy |
3.8% |
| Weight Increased |
3.8% |
| Grand Mal Convulsion |
3.1% |
| Urinary Retention |
3.1% |
| Urinary Tract Infection |
3.1% |
| Abnormal Weight Gain |
2.5% |
| Head Injury |
2.5% |
| Loss Of Consciousness |
2.5% |
| Potentiating Drug Interaction |
2.5% |
| Status Epilepticus |
2.5% |
|
